Tenofovir gel use associated with lower HSV-2 risk in women

Analysis found risk reduced by 46 percent in women who used gel regularly; Affirms results of CAPRISA 004 trialThe risk of acquiring herpes simplex virus type 2 (HSV-2) was reduced by half among...